Omalizumab use in pregnancy showed comparable birth results with asthma …
Healio Prevalence of congenital defects, prematurity and low birth weight in infants of mothers treated with omalizumab during pregnancy were comparable with the general population with asthma, according to recent study results. “Asthma affected 8.4% to 8.8 … |
View full post on asthma – Google News